Background Immune checkpoint therapy has dramatically changed the landscape of cancer
therapy, providing an efficacious and durable therapeutic option for patients with advanced-…

Background Radium‐223 dichloride (Ra‐223) is a targeted alpha therapy that induces
localized cytotoxicity in bone metastases. We evaluated the efficacy and safety of Ra‐223 plus …

Objective Thorough evaluation of the musculoskeletal system on PET/CT requires a fund of
specialized knowledge and the use of musculoskeletal-oriented viewing techniques. The …

4099 Background: The final per-protocol statistical analysis (cut–off date 24 July 2015) of PFS,
the primary endpoint of the NETTER-1 study, showed a significant difference (p < 0.0001) …

Objective. The default window setting on PET/CT workstations is soft tissue. This study
investigates whether bone windowing and hybrid FDG PET/CT can help differentiate between …

Purpose: To evaluate the feasibility of fast Dixon whole‐body (WB) magnetic resonance
imaging (MRI) for detecting bone and liver metastasis in clinical patients and to compare its …

We report the impact of 177 Lu-DOTATATE treatment on abdominal pain, diarrhea, and
flushing, symptoms that patients with advanced midgut neuroendocrine tumors often find …

Important progress has been made over the last decade in the classification, imaging, and
treatment of neuroendocrine neoplasm (NENs), with several new agents approved for use. …

Purpose: This paper aims to evaluate the safety and efficacy of the temporary redirection of
blood flow of hepatoenteric collaterals using a balloon catheter in the common hepatic artery (…

4102 Background: Might potential nephrotoxicity be a risk for therapy with 177Lu-Dotatate?
Among patients randomised in the NETTER-1 study, nephrotoxicity and treatment efficacy …